The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family

Completed

Conditions studied: Financial Impact of Stem Cell Transplantation

In brief

The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.

Key facts

Study ID

NCT00795054

Run by

Center for International Blood and Marrow Transplant Research

People needed

30

Starts

2009-03-01

Expected to finish

2015-08-01

Last updated by the study team

2015-10-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult recipients and parents/guardians of pediatric (age 0-17 years) recipients of allogeneic HSCT
• Recipient has a primary caregiver, who is a member of the recipient's household
• Allogeneic HSCT using any donor cell source (related, unrelated, or cord blood)
• Any age at HSCT
• Diagnosis of primary disease for which HSCT is being performed must have been made within two years prior to transplantation
• Adult recipients, parents/guardians of pediatric recipients, and primary caregivers should be able to read, write, and understand the English language
• Signed informed consent from adult patient, caregiver and/or parent/guardian for study participation
• Signed consent to participate in the Center for International Blood and Marrow Transplant Research (CIBMTR) research database.

You may not qualify if…

• Recipients who have had a previous HSCT (autologous or allogeneic)
• Households with more than one transplant recipient

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.